Sciaticyl uses Turmeric standardised to 95% curcumin, the highest standardisation level available, at a dose higher than most competitor formulas. Curcumin inhibits NF-kB, the master transcription factor controlling production of inflammatory cytokines, prostaglandins, and chemokines throughout the body. At meaningful doses with a bioavailability enhancer (BioPerine black pepper extract is paired with Turmeric in this formula), curcumin's anti-inflammatory activity is potent enough to rival pharmaceutical anti-inflammatory compounds in some research contexts. It is the centrepiece of Sciaticyl's anti-inflammatory strategy.

Boswellia AKBA inhibits 5-lipoxygenase, blocking leukotriene production in the nerve tissue inflammatory cascade. Ginger Root inhibits COX-1 and COX-2 enzymes and prostaglandin E2 synthesis, reducing neurogenic inflammation through a complementary pathway. Quercetin stabilises mast cells to reduce histamine release and also inhibits multiple inflammatory kinase enzymes. Together with Turmeric, these four compounds block the four major inflammatory signalling pathways simultaneously, producing broader anti-inflammatory coverage than any two-herb combination can.

ALA provides the essential mitochondrial antioxidant protection that nerve cells require independent of inflammation status. Methylcobalamin B12 at 1000mcg maintains myelin sheath integrity in the affected nerve fibres. Vitamin D3 at 2000 IU addresses the Vitamin D status that research has associated with nerve comfort sensitivity, adequate Vitamin D supports healthy nerve signalling threshold and reduces peripheral nervous system inflammatory vulnerability.